ARCHIVES

Nexavar Improves PFS In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

DCT Board Approves New Imaging Study In Split Vote, Small Grant Program

October 27, 1989

Biomed Research Absent from Bush State of the Union.

January 26, 2007

In Brief: Ozer, Comis Join Allegheny Cancer Centers; Two Cooperative Groups Under Same Roof

March 21, 1997

Drug Development Gets Extra $500,000

November 18, 1977